Rankings
▼
Calendar
RCKT Q4 2016 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RCKT
Rocket Pharmaceuticals, Inc.
$538M
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$12M
Net Income
-$13M
EPS (Diluted)
$-1.92
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$931,000
Balance Sheet
Total Assets
$130M
Total Liabilities
$56M
Stockholders' Equity
$73M
Cash & Equivalents
$30M
← FY 2016
All Quarters
Q1 2017 →
